COPD

Inhaler Therapy for COPD-An individualised approach to inhaler selection

Inhaler Therapy for COPD An individualised approach to inhaler selection

Adherence and inhaler satisfaction together predict improved health outcomes for patients with chronic obstructive pulmonary disease (COPD). Assessment of a patient’s co-ordination and inspiratory flow patterns should guide selection of inhaler devices. Adherence and device technique should be assessed regularly and before changing a patient’s therapy. Patients should use only one type of device for all of their inhaled therapies, where possible.

Modern Medicine – Issue 2 2022

April 11, 2022 by COPD

COPD Exacerbations A hearty opportunity

COPD Exacerbations A hearty opportunity

Chronic obstructive pulmonary disease (COPD) exacerbations are common and are times of physiological stress resulting in heightened cardiovascular risk in individuals at high risk of cardiovascular disease. COPD exacerbations can reveal cardiovascular disease and are an opportunity for cardiovascular risk assessment . COPD exacerbations are opportunities to make a difference to both pulmonary and cardiac outcomes.

Modern Medicine – Issue 6 2021

December 1, 2021 by COPD

Asthma, COPD and When They Coexist

Asthma, COPD and When They Coexist

Asthma and chronic pulmonary obstructive disease (COPD) are umbrella terms that describe disorders of the airways with diverse inflammatory pathways and pathophysiology. Recent advances in the understanding of the immunopathology of asthma have led to the emergence of biological agents that more precisely target disease pathways but will require a more precise understanding of those dysfunctional pathways. There are areas where the pathology and expression of airways disease in asthma and COPD overlap. The overlap between asthma and COPD presents important challenges in diagnosis as well as management.

Modern Medicine – Oct/Nov 2018

November 8, 2018 by Asthma COPD

Asthma – COPD Overlap Syndrome | A merger of 2 distinct spectrums of inflammatory airway diseases

Asthma – COPD Overlap Syndrome | A merger of 2 distinct spectrums of inflammatory airway diseases – MM1609

Most practising doctors are familiar with the diseases of Asthma and Chronic Obstructive Pulmonary Disease (COPD). Within the cohort of these two disease entities, there are patients that do not completely satisfy the criteria to be diagnosed convincingly as either asthma or COPD. While the semantics of these diseases are far more important for research purposes than the diagnostic dilemma they pose, there have been several advances in both asthma and COPD that make the distinction or recognition of an asthma COPD Overlap Syndrome (ACOS) as a clinical entity more pertinent.

Modern Medicine – September 2016

October 6, 2016 by Asthma COPD Pulmonology

Putting COPD Medications into Perspective

Putting COPD Medications into Perspective – MM1601

Over the past few years, new drugs have been added to the bronchodilators and inhaled corticosteroids used for treating COPD. There is no strong evidence to say that one drug within a class is better than another and the decision about which drugs to use is mainly about patient preference, although multiple drugs from the same class should not be used in the same patient.

Modern Medicine – January 2016

January 14, 2016 by COPD Pulmonology
Verified by ExactMetrics